Hyperphosphatemia Treatment Market
Hyperphosphatemia is a serum phosphate concentration?>?4.5 mg/dL (>?1.46 mmol/L). Causes include chronic kidney disease, hypoparathyroidism, and metabolic or respiratory acidosis. Clinical features may be due to accompanying hypocalcemia and include tetany. Diagnosis is by serum phosphate measurement. Treatment includes restriction of phosphate intake and administration of phosphate-binding antacids, such as calcium carbonate. This report contains market size and forecasts of Hyperphosphatemia Treatment in Global, including the following market information: Global Hyperphosphatemia Treatment Market Revenue, 2018-2023, 2023-2030, ($ millions) Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-hyperphosphatemia-treatment-forecast-2023-2030-217 The global Hyperphosphatemia Treatment market was valued at million in 2022 and is proj...